Theralase cash burn latest private placementTheralase are going for the $10 Million private placement. The latest financial statements has all executives receiving raises on their annual salaries. Given the cash burn, the delayed timelines and the fact that Theralase is not profitable. Is it not reasonable that executives scale back their salaries and take equity in the company instead? Big Pharma pay people very well, but that also have huge profits to draw that compensation from.
I'm wondering if the people bringing this medical technology across the finish line have as much to gain or lose, as all the investors who have actually been financing this venture.
I hope they signal to the investment community that they are willing to sacrifice and put their reward directly linked to the success of TLT.